Published in TB and Outbreaks Week, July 2nd, 2002
Cathal E. O'Sullivan and colleagues at the National Cancer Institute in Bethesda, Maryland, and the Mayo Clinic and Foundation in Rochester, Minnesota, evaluated the Amplified Mycobacterium Tuberculosis Direct (AMTD) test from San Diego-based Gen-Probe, Inc.
This tuberculosis screen was both highly accurate and significantly faster than conventional diagnostic techniques, O'Sullivan and coauthors found.
The researchers assessed the AMTD assay's ability to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.